Literature DB >> 11740740

Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines.

M H Slack1, D Schapira, R J Thwaites, M Burrage, J Southern, N Andrews, R Borrow, D Goldblatt, E Miller.   

Abstract

To determine the immune response of premature infants to meningococcal serogroup C capsular polysaccharide (MCC) and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b (DTaP-Hib) conjugate vaccines, 105 infants born at <32 weeks' gestation had Hib IgG geometric mean concentrations (GMCs) and MCC serum bactericidal antibody (SBA) geometric mean titers (GMTs) measured 1 month after the third immunization. Term infants served as control subjects. Premature infants had Hib GMCs of 0.27 microg/mL, with 21% achieving GMCs >1.0 microg/mL, compared with 0.81 microg/mL and 46% in term infants (P<.001 and P=.003, respectively). The MCC SBA GMT was 398, with 99% achieving an SBA > or =8, compared with 380 and 98% in term infants (P=.84 and P=1.0, respectively). Hib IgG was associated with age at third immunization (P<.001). When combined with the DTaP vaccine used in this study, the Hib GMC of premature infants was extremely low. The SBA GMT to MCC was similar to that of term infants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11740740     DOI: 10.1086/324666

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure.

Authors:  J McVernon; P D R Johnson; A J Pollard; M P E Slack; E R Moxon
Journal:  Arch Dis Child       Date:  2003-05       Impact factor: 3.791

2.  Effect of a fourth Haemophilus influenzae type b immunisation in preterm infants who received dexamethasone for chronic lung disease.

Authors:  P Clarke; P J Powell; D Goldblatt; M J Robinson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

Review 3.  Immunization of preterm infants.

Authors:  Arnaud Gagneur; Didier Pinquier; Caroline Quach
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 4.  Immunisation of premature infants.

Authors:  J Bonhoeffer; C-A Siegrist; P T Heath
Journal:  Arch Dis Child       Date:  2006-11       Impact factor: 3.791

Review 5.  Factors That Influence the Immune Response to Vaccination.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2019-03-13       Impact factor: 26.132

6.  DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation.

Authors:  M H Slack; S Cade; D Schapira; R J Thwaites; A Crowley-Luke; J Southern; R Borrow; E Miller
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

7.  Association of Routine Infant Vaccinations With Antibody Levels Among Preterm Infants.

Authors:  Elsbeth D M Rouers; Patricia C J Bruijning-Verhagen; Pieter G M van Gageldonk; Josephine A P van Dongen; Elisabeth A M Sanders; Guy A M Berbers
Journal:  JAMA       Date:  2020-09-15       Impact factor: 56.272

8.  Responses to a fourth dose of Haemophilus influenzae type B conjugate vaccine in early life.

Authors:  M H Slack; D Schapira; R J Thwaites; M Burrage; J Southern; D Goldblatt; E Miller
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-05       Impact factor: 5.747

9.  Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom.

Authors:  Jo Southern; Ray Borrow; Nick Andrews; Rhonwen Morris; Pauline Waight; Michael Hudson; Paul Balmer; Helen Findlow; Jamie Findlow; Elizabeth Miller
Journal:  Clin Vaccine Immunol       Date:  2008-12-17

10.  Acellular pertussis vaccine given by accelerated schedule: response of preterm infants.

Authors:  M H Slack; D Schapira; R J Thwaites; C Schapira; J Bamber; M Burrage; J Southern; N Andrews; E Miller
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-01       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.